Showing results (11-20 of 53) with videos related to
Sort By:
Pageof 6
Circulation|January 8, 2003
TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesionsEberhard Grube, Sigmund Silber, Karl Eugen Hauptmann, et al.The American Journal of Cardiology|June 28, 2005
Two-year-plus follow-up of a paclitaxel-eluting stent in de novo coronary narrowings (TAXUS I)Eberhard Grube, Sigmund Silber, Karl Eugen Hauptmann, et al.Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|November 2, 2002
Echocardiography improves detection of rejection after heterotopic mouse cardiac transplantationMarielle Scherrer-Crosbie, Troels Glysing-Jensen, Stefanie J Fry, et al.Journal of the American College of Cardiology|April 20, 2005
Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary arteryGeorge Dangas, Stephen G Ellis, Richard Shlofmitz, et al.Circulation|December 14, 2005
Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II studyJiro Aoki, Antonio Colombo, Dariusz Dudek, et al.JACC. Cardiovascular Interventions|May 21, 2011
Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS Clinical Trial ProgramGregg W Stone, Stephen G Ellis, Antonio Colombo, et al.Circulation|August 6, 2003
Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesionsAntonio Colombo, Janusz Drzewiecki, Adrian Banning, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 25, 2006
Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phaseArie Pieter Kappetein, Keith D Dawkins, Friedrich W Mohr, et al.The American Journal of Cardiology|March 11, 2005
Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial)Eugenia Nikolsky, Edward Kosinski, Gregory J Mishkel, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
Integrated analysis of medically treated diabetic patients in the TAXUS(R) program: benefits across stent platforms, paclitaxel release formulations, and diabetic treatmentsKeith D Dawkins, Gregg W Stone, Antonio Colombo, et al.Pageof 6